Toxicology of long-term and high-dose administration of methylphenidate on the kidney tissue - a histopathology and molecular study

Toxicol Mech Methods. 2020 Oct;30(8):611-619. doi: 10.1080/15376516.2020.1805665. Epub 2020 Sep 3.

Abstract

The present study aims to assess the influences of oral methylphenidate on kidney function and structure versus vehicle treatment in adult male rats. In this study, thirty adult male rats equally into two treatment groups divided randomly, and among them, MPH has been administered for 21 days, at doses of 20 mg/kg, and the control group has received salin. In renal, under the effect of MPH applying quantitative real-time PCR, we analyzed nephrotoxicity-related molecular pathways like autophagy, inflammation, and apoptosis. Moreover, the levels of GSH, CAT, and SOD were investigated as antioxidant enzymes. Afterward, stereological analysis in MPH-treated rats has been performed. Analysis of qPCR displayed inflammation, impaired autophagy, and enhanced apoptosis with histological changes in the kidney's tissue, also an important rise in the antioxidant enzymes' level. Besides, 20 mg/kg of MPH led to a decline in the mean of Bowman's space thickness and renal corpuscle's volume in comparison to the control rats. Collectively, our histological and molecular data implicit that in the kidney region, administrating of MPH evoked discriminative expression alterations in nephrotoxicity-associated signaling cascades, specifically autophagy, inflammation, and apoptosis paired with important damage to kidney tissue.

Keywords: Autophagy; apoptosis; inflammation; kidney; methylphenidate; nephrotoxicity.

MeSH terms

  • Administration, Oral
  • Animals
  • Apoptosis / drug effects*
  • Autophagy / drug effects*
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / toxicity*
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / genetics
  • Kidney Diseases / metabolism
  • Kidney Diseases / pathology
  • Male
  • Methylphenidate / administration & dosage
  • Methylphenidate / toxicity*
  • Oxidative Stress / drug effects
  • Rats, Wistar
  • Signal Transduction
  • Time Factors

Substances

  • Central Nervous System Stimulants
  • Methylphenidate